ArticleOncotarget2016

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors.

Ariunzaya Bat-Erdene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.